Filing Flows › cbdMD (YCBD) › Q1 FY26
cbdMD (YCBD) Q1 FY26 earnings results (first quarter fiscal 2026)
10-Q filed Feb 17, 2026
cbdMD (YCBD) reported revenue of $5.0M for the first quarter fiscal 2026 (Q1 FY26), -2% from a year earlier and +6% from the quarter before. Operating margin was -5.7%, net loss $283K (5.6% of revenue).
cbdMD, Q1 FY26: revenue $5.0M (-2% year over year), operating margin -5.7%, net loss $283K, operating cash flow −$812K. The chart follows the revenue to costs, profit and cash.
| Q1 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.0M | +6% | -2% |
| Operating profit | −$286K | — | — |
| Net earnings | −$283K | — | — |
| Operating cash flow | −$812K | — | — |
What changed
Revenue was $5.0M in Q1 FY26, down 2% year over year and up 6% from the previous quarter.
Gross margin was 59.8%, down 6.7 points from a year earlier. Operating costs exceeded revenue by $286K, an operating margin of -5.7%. Operating expenses fell 6% while revenue fell 2%. The quarter ended with a net loss of $283K, narrower than the previous quarter's $680K loss.
Operating cash flow was −$812K. Non-cash charges added back $245K of depreciation and amortization. Working capital and other items used $775K. Capital expenditures of $165K exceeded it, leaving free cash flow of −$1.0M.
Questions
What was cbdMD's revenue in the first quarter fiscal 2026?
cbdMD (YCBD) reported revenue of $5.0M for the first quarter fiscal 2026 (Q1 FY26), -2% from a year earlier and +6% from the quarter before.
Was cbdMD profitable in the first quarter fiscal 2026?
Operating loss was $286K (-5.7% of revenue) and net loss $283K.
Source: cbdMD 10-Q on SEC EDGAR.